Ilsung Pharm (003120) - Total Liabilities

Latest as of March 2026: ₩24.00 Billion KRW ≈ $16.27 Million USD

Based on the latest financial reports, Ilsung Pharm (003120) has total liabilities worth ₩24.00 Billion KRW (≈ $16.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Ilsung Pharm to see how much of total assets are deployed in long-term investments.

Ilsung Pharm - Total Liabilities Trend (2013–2025)

This chart illustrates how Ilsung Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Ilsung Pharm total assets.

Ilsung Pharm Competitors by Total Liabilities

The table below lists competitors of Ilsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Nicola Mining Inc V:NIM	Canada	CA$17.60 Million
Bcl Industries Limited NSE:BCLIND	India	Rs6.97 Billion
Orbitech Co. Ltd KQ:046120	Korea	₩56.53 Billion
Taseco Air Services JSC VN:AST	Vietnam	₫298.09 Billion
Biosolution Co.Ltd KQ:086820	Korea	₩36.25 Billion
Faraday Future Intelligent Electric Inc NASDAQ:FFIE	USA	$339.87 Million
Daishin Information & Communications Co.Ltd KQ:020180	Korea	₩116.84 Billion
Stillwater Critical Minerals Corp V:PGE	Canada	CA$681.37K

Liability Composition Analysis (2013–2025)

This chart breaks down Ilsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Ilsung Pharm balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	12.24	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilsung Pharm (2013–2025)

The table below shows the annual total liabilities of Ilsung Pharm from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩16.67 Billion ≈ $11.29 Million	+41.89%
2024-12-31	₩11.75 Billion ≈ $7.96 Million	-67.77%
2023-12-31	₩36.44 Billion ≈ $24.69 Million	-25.42%
2022-12-31	₩48.85 Billion ≈ $33.11 Million	+91.78%
2021-12-31	₩25.47 Billion ≈ $17.26 Million	+7.26%
2020-12-31	₩23.75 Billion ≈ $16.09 Million	-1.16%
2019-12-31	₩24.03 Billion ≈ $16.28 Million	+4.79%
2018-12-31	₩22.93 Billion ≈ $15.54 Million	-6.93%
2017-12-31	₩24.64 Billion ≈ $16.70 Million	+33.88%
2016-12-31	₩18.40 Billion ≈ $12.47 Million	-62.20%
2015-12-31	₩48.69 Billion ≈ $32.99 Million	-2.02%
2014-12-31	₩49.69 Billion ≈ $33.67 Million	-0.45%
2013-12-31	₩49.92 Billion ≈ $33.83 Million	--

About Ilsung Pharm

KO:003120 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$105.81 Million

₩156.13 Billion KRW

Market Cap Rank

#19084 Global

#923 in Korea

Share Price

₩21800.00

Change (1 day)

-1.13%

52-Week Range

₩18300.00 - ₩28300.00

All Time High

₩31693.76